Postes actifs de Karim Dabbagh
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MAAT PHARMA | Président | 21/06/2023 | - |
| Independent Dir/Board Member | 21/06/2023 | - |
Historique de carrière de Karim Dabbagh
Anciens postes connus de Karim Dabbagh
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Second Genome, Inc.
 Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Directeur/Membre du Conseil | 11/09/2018 | 01/09/2023 |
| Directeur Général | 11/09/2018 | 01/09/2023 | |
| Directeur Technique/Scientifique/R&D | 01/01/2014 | 01/12/2020 | |
| President | 11/09/2018 | 01/09/2023 | |
| Modus Biomedicine, Inc. | Directeur Général | 01/08/2009 | 01/12/2010 |
| Fondateur | 01/08/2009 | 01/12/2010 |
Formation de Karim Dabbagh
| University College London | Doctorate Degree |
| Imperial College London | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| Royaume-Uni | 3 |
| France | 2 |
Opérationnelle
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MAAT PHARMA | Health Technology |
| Entreprise privées | 2 |
|---|---|
Second Genome, Inc.
Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Health Technology |
| Modus Biomedicine, Inc. |
- Bourse
- Insiders
- Karim Dabbagh
- Expérience
